Inicio
Explorar
nav.journalClub
Tendencias
Más
synapse
⌘+K
Idioma
Español
Español
March 3, 2026
Using intravesical botulinum toxin as an adjunct during urologic surgery: a systematic review
SR
Suditi Rahematpura
JM
Joanna Marantidis
AW
Amanda Wibben
Ver todo
Puntos clave
Adjunctive use of intravesical botulinum toxin may enhance surgical outcomes in urologic procedures, improving patient recovery.
Systematic review reveals better postoperative results with botulinum toxin, favoring patients undergoing bladder-related surgeries.
Analysis of multiple studies indicates the effectiveness of botulinum toxin as an adjunct in urologic surgery settings.
Findings highlight the need for further exploration of botulinum toxin's role in various surgical approaches within urology.
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Mark Helpful
Me gusta
Save
Guardar
Relay
Compartir
Cite This Study
Copy
Rahematpura et al. (Thu,) studied this question.
synapsesocial.com/papers/69a75d99c6e9836116a27c69
https://doi.org/https://doi.org/10.1007/s00345-025-06136-9
Using intravesical botulinum toxin as an adjunct during urologic surgery: a systematic review | Synapse